These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26340092)

  • 1. Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability.
    Cao L; Ding J; Dong L; Zhao J; Su J; Wang L; Sui Y; Zhao T; Wang F; Jin J; Cai Y
    PLoS One; 2015; 10(9):e0137411. PubMed ID: 26340092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin.
    Ding J; Yu C; Sui Y; Wang L; Yang Y; Wang F; Yao H; Xing F; Liu H; Li Y; Shah JA; Cai Y; Jin J
    FEBS J; 2018 Sep; 285(17):3270-3285. PubMed ID: 30055111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells.
    Su J; Sui Y; Ding J; Li F; Shen S; Yang Y; Lu Z; Wang F; Cao L; Liu X; Jin J; Cai Y
    Protein Cell; 2016 Oct; 7(10):749-760. PubMed ID: 27535137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21
    Sui Y; Wu T; Li F; Wang F; Cai Y; Jin J
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31035388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the Chromatin Remodeling Protein hINO80 with DNA.
    Mendiratta S; Bhatia S; Jain S; Kaur T; Brahmachari V
    PLoS One; 2016; 11(7):e0159370. PubMed ID: 27428271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
    Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
    Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
    Fischer M; Quaas M; Nickel A; Engeland K
    Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner.
    Kramer HB; Lai CF; Patel H; Periyasamy M; Lin ML; Feller SM; Fuller-Pace FV; Meek DW; Ali S; Buluwela L
    Nucleic Acids Res; 2016 Jan; 44(2):582-94. PubMed ID: 26400164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes.
    Fischer M; Quaas M; Steiner L; Engeland K
    Nucleic Acids Res; 2016 Jan; 44(1):164-74. PubMed ID: 26384566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
    Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
    Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
    Li H; Wu X
    Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurr1 promotes intestinal regeneration after ischemia/reperfusion injury by inhibiting the expression of p21 (Waf1/Cip1).
    Zu G; Yao J; Ji A; Ning S; Luo F; Li Z; Feng D; Rui Y; Li Y; Wang G; Tian X
    J Mol Med (Berl); 2017 Jan; 95(1):83-95. PubMed ID: 27553040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
    Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
    Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammalian INO80 chromatin remodeler cooperates with FANCM to mediate DNA interstrand crosslink-induced checkpoint activation and repair.
    Andreev V; Hristova R; Asparuhova M; Danovski G; Stoynov S; Gospodinov A
    DNA Repair (Amst); 2019 Feb; 74():38-50. PubMed ID: 30606611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells.
    Karkhanis M; Park JI
    Cell Signal; 2015 Mar; 27(3):479-86. PubMed ID: 25595558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression.
    Xu H; Wang Z; Jin S; Hao H; Zheng L; Zhou B; Zhang W; Lv H; Yuan Y
    Biochem Biophys Res Commun; 2014 Mar; 446(1):235-40. PubMed ID: 24589735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SKIP counteracts p53-mediated apoptosis via selective regulation of p21Cip1 mRNA splicing.
    Chen Y; Zhang L; Jones KA
    Genes Dev; 2011 Apr; 25(7):701-16. PubMed ID: 21460037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.